325 results
Page 4 of 17
8-K
j7688 o4dzipa0tg1z8
27 Oct 14
Other Events
12:00am
8-K
EX-99.1
kmpr1c
27 Oct 14
Other Events
12:00am
8-K
sgs3o36b ko
21 Oct 14
Regulation FD Disclosure
12:00am
8-K
EX-99
7o603ly t8
17 Oct 14
Other Events
12:00am
8-K
yfi7zkkkh9qxrc949i
17 Oct 14
Other Events
12:00am
8-K
EX-99.2
cusoy4scqzqc
8 Sep 14
Other Events
12:00am
8-K
EX-99.1
wsenrsx2l49zrwif xm2
8 Sep 14
Other Events
12:00am
8-K
EX-99.5
xqev3n 61rn
8 Sep 14
Other Events
12:00am
8-K
EX-99.4
byp2zy ceddid
8 Sep 14
Other Events
12:00am
8-K
EX-99.1
wl8tptym dd671qs
9 Jul 14
Anoro® Ellipta® (umeclidinium/vilanterol) approved in Australia for Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-99
7nii5 wpsy
7 Jul 14
Other Events
12:00am
8-K
EX-99.1
nwjpo5ppgf1ah7
21 May 14
Regulation FD Disclosure
12:00am
8-K
EX-99
xrwf74
28 Apr 14
Financial Statements and Exhibits
12:00am
8-K
EX-99.1
r2069m
22 Apr 14
Breo™Ellipta® (fluticasone furoate/vilanterol trifenatate) approved in Australia for Asthma and Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-10.8
qnni398kuyq83wwj8
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-99.1
8no3s
9 Apr 14
Regulation FD Disclosure
12:00am